171 related articles for article (PubMed ID: 7459898)
21. [Treatment of metastatic malignant melanoma (author's transl)].
Kühböck J; Pehamberger H; Mach K; Diem E; Kokoschka EM; Pötzi P
Wien Klin Wochenschr; 1978 Dec; 90(24):856-8. PubMed ID: 84441
[TBL] [Abstract][Full Text] [Related]
22. [Photosensitization with DTIC therapy in metastatic malignant melanoma].
Bolling R; Meyer-Hamme S; Schauder S
Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142
[TBL] [Abstract][Full Text] [Related]
23. [Phase II study of decarbazine (DTIC) in malignant melanoma. DTIC Research Group].
Ishihara K
Gan To Kagaku Ryoho; 1986 May; 13(5):1940-5. PubMed ID: 3707154
[TBL] [Abstract][Full Text] [Related]
24. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
Carbone PP; Costello W
Cancer Treat Rep; 1976 Feb; 60(2):193-8. PubMed ID: 769973
[TBL] [Abstract][Full Text] [Related]
25. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
[TBL] [Abstract][Full Text] [Related]
26. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
[TBL] [Abstract][Full Text] [Related]
27. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
[TBL] [Abstract][Full Text] [Related]
28. Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities.
Vaglini M; Belli F; Marolda R; Prada A; Santinami M; Cascinelli N
Eur J Surg Oncol; 1987 Apr; 13(2):127-9. PubMed ID: 3556593
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial.
Ravaud A; Delaunay M; Chevreau C; Coulon V; Debled M; Bret-Dibat C; Courbon F; Gualde N; Nguyen Bui B
Br J Cancer; 2001 Nov; 85(10):1467-71. PubMed ID: 11720430
[TBL] [Abstract][Full Text] [Related]
30. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
31. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
Hill HZ; Hill GJ
Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of intermittent high-dose dacarbazine.
Buesa JM; Gracia M; Valle M; Estrada E; Hidalgo OF; Lacave AJ
Cancer Treat Rep; 1984 Mar; 68(3):499-504. PubMed ID: 6704980
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI
Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692
[TBL] [Abstract][Full Text] [Related]
34. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
Carmo-Pereira J; Oliveira Costa F; Pimentel P
Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
[No Abstract] [Full Text] [Related]
35. Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
Gardere S; Hussain S; Cowan DH
Cancer Chemother Rep; 1972 Jun; 56(3):357-61. PubMed ID: 19051495
[TBL] [Abstract][Full Text] [Related]
36. Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine.
van Hazel GA; Rubin J; Moertel CG
Cancer Treat Rep; 1983 Jun; 67(6):583-5. PubMed ID: 6861165
[TBL] [Abstract][Full Text] [Related]
37. DTIC (NSC-45388) studies in the southwest oncology group.
Costanzi JJ
Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
[TBL] [Abstract][Full Text] [Related]
38. Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma.
Abdi EA; McPherson TA; Tan YH
J Biol Response Mod; 1986 Oct; 5(5):423-8. PubMed ID: 3772395
[TBL] [Abstract][Full Text] [Related]
39. Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea.
Bellet RE; Catalano RB; Mastrangelo MJ; Berd D
Cancer Treat Rep; 1978 Dec; 62(12):2095-9. PubMed ID: 751717
[TBL] [Abstract][Full Text] [Related]
40. [DTIC in malignant melanoma: a perspective (author's transl)].
Kokoschka EM
Wien Klin Wochenschr; 1978 Dec; 90(24):870-4. PubMed ID: 369152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]